| http://dbpedia.org/ontology/abstract
|
Dextran drug delivery systems involve the … Dextran drug delivery systems involve the use of the natural glucose polymer dextran in applications as a prodrug, nanoparticle, microsphere, micelle, and hydrogel drug carrier in the field of targeted and controlled drug delivery. According to several in vitro and animal research studies, dextran carriers reduce off-site toxicity and improve local drug concentration at the target tissue site. This technology has significant implications as a potential strategy for delivering therapeutics to treat cancer, cardiovascular diseases, pulmonary diseases, bone diseases, liver diseases, colonic diseases, infections, and HIV. Although there are many FDA approved natural polymeric-based drug carriers available for clinical use, dextran has failed to obtain any clinical applications. Research must address several challenges and obstacles associated with dextran before it can become a viable, clinically approved drug delivery strategy.linically approved drug delivery strategy.
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Dextran.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
70644950
|
| http://dbpedia.org/ontology/wikiPageLength
|
19386
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1117101287
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/File:Figure_3.0_-_Drug-loaded_dextran_micelle.png +
, http://dbpedia.org/resource/File:Figure_4.0_-_Drug-loaded_dextran_cross-linked_hydrogels.png +
, http://dbpedia.org/resource/In_vitro +
, http://dbpedia.org/resource/MicroRNA +
, http://dbpedia.org/resource/Disulfide_bond +
, http://dbpedia.org/resource/Iron_oxide +
, http://dbpedia.org/resource/Category:Drug_delivery_devices +
, http://dbpedia.org/resource/Polycaprolactone +
, http://dbpedia.org/resource/File:Dextran.png +
, http://dbpedia.org/resource/Retinoic_acid +
, http://dbpedia.org/resource/Epichlorohydrin +
, http://dbpedia.org/resource/Esterase +
, http://dbpedia.org/resource/Hydrogel +
, http://dbpedia.org/resource/Nanoparticle +
, http://dbpedia.org/resource/Biodegradation +
, http://dbpedia.org/resource/Hydrolysis +
, http://dbpedia.org/resource/Biocompatibility +
, http://dbpedia.org/resource/Prodrug +
, http://dbpedia.org/resource/Folic_acid +
, http://dbpedia.org/resource/Drug_carrier +
, http://dbpedia.org/resource/Microparticle +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Ester +
, http://dbpedia.org/resource/Polyethylene_glycol +
, http://dbpedia.org/resource/Dextran +
, http://dbpedia.org/resource/PLGA +
, http://dbpedia.org/resource/Micelle +
, http://dbpedia.org/resource/File:Figure_2.0_-_Drug-loaded_dextran_nanoparticles.png +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Short_description +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Drug_delivery_devices +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Dextran_drug_delivery_systems?oldid=1117101287&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Dextran.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/Figure_3.0_-_Drug-loaded_dextran_micelle.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/Figure_4.0_-_Drug-loaded_dextran_cross-linked_hydrogels.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/Figure_2.0_-_Drug-loaded_dextran_nanoparticles.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Dextran_drug_delivery_systems +
|
| owl:sameAs |
http://dbpedia.org/resource/Dextran_drug_delivery_systems +
|
| rdfs:comment |
Dextran drug delivery systems involve the … Dextran drug delivery systems involve the use of the natural glucose polymer dextran in applications as a prodrug, nanoparticle, microsphere, micelle, and hydrogel drug carrier in the field of targeted and controlled drug delivery. According to several in vitro and animal research studies, dextran carriers reduce off-site toxicity and improve local drug concentration at the target tissue site. This technology has significant implications as a potential strategy for delivering therapeutics to treat cancer, cardiovascular diseases, pulmonary diseases, bone diseases, liver diseases, colonic diseases, infections, and HIV.es, colonic diseases, infections, and HIV.
|
| rdfs:label |
Dextran drug delivery systems
|
